ESC Congress 2013

Ai Mediq S.A. took part in traditional and the largest cardiological event in year – European Society of Cardiology Congress. This year the congress was from August 31 to September 4 in the exhibition center RAI in Amsterdam. At the Ai Mediq booth participants got acquainted and learned in detail the unique device for hypoxic therapy – ReOxy. The specialists of the company showed the…

Effect of hypoxic training on inflammatory and metabolic risk factors: a crossover study in healthy subjects.

The purpose of this study was to investigate the influence of hypoxic physical exercise on metabolic syndrome (MS) risk markers and high-sensitivity C-reactive protein (CRP) and to compare its effects on preperitoneal fat, arterial stiffness, and several blood parameters related to MS to those of a control group who trained under normoxic conditions. Fourteen healthy men were examined. Participants performed treadmill exercise 3 days per…

Trends in the use of preconditioning to hypoxia for early prevention of future life diseases

Environmental factors during fetal life program the health outcomes regarding many diseases in future life. This idea has been supported by worldwide epidemiological studies, but the underlying mechanisms are still poorly understood. Three questions should be answered. (i) Does a common underlying cause of ordinary pathological fetal development exist? (ii) If such a cause exists, which mechanism might develop disease in later life? (iii) Is…

Singapore Prevention & Cardiac Rehabilitation Symposium 2017

Ai Mediq S.A. is happy to inform our friends and colleagues about the Singapore Prevention & Cardiac Rehabilitation Symposium 2017 that was hosted on 20-21 October 2017 in Novotel Singapore Clarke Quay. Visitors were encouraged to attend a poster session in general and poster O-45 specifically that will be presented by world-renowned specialist in the field of Hypoxia treatment – Prof. Oleg Glazachev. Prof. Glazachev’s…